| Budenofalk granules (budesonide gastro-resistant granules) / Dr Falk |
| Completed | 3 | 343 | Europe | budesonide, Budenofalk 3mg capsules, mesalazine, Salofalk 1000mg granules | Dr. Falk Pharma GmbH | Colitis, Ulcerative | 08/08 | 08/10 | | |
| Completed | 3 | 92 | Europe | Budesonide, Mesalazine, Placebo | Dr. Falk Pharma GmbH | Collagenous Colitis | 06/11 | 08/11 | | |
| Completed | 3 | 44 | Europe | Budesonide granules 9 mg, Placebo granules | Dr. Falk Pharma GmbH | Incomplete Microscopic Colitis | 02/20 | 02/20 | | |
NCT04208581: Yiqi Huoxue Huatan Granule for Reducing Mortality in COPD With Chronic Respiratory Failure |
|
|
| Unknown status | 3 | 372 | RoW | Yiqi Huoxue Huatan granule, Tiotropium Bromide Powder for Inhalation, Salmeterol / Fluticasone Powder for Inhalation or Budesonide / Formoterol Powder for Inhalation, Placebo Yiqi Huoxue Huatan granule | Peking University People's Hospital, The Affiliated Hospital of Liaoning University of TCM | Chronic Obstructive Pulmonary Disease, Chronic Respiratory Failure | 12/21 | 12/21 | | |
2019-003334-16: Novel budenosid suppository in addition to basic therapy with oral mesalazine compared to basic therapy alone for treatment of ulcerative colitis |
|
|
| Not yet recruiting | 3 | 360 | Europe, RoW | Budenofalk® suppositories, Salofalk 3g gastro-resistant prolonged-release granules, Suppository, Gastro-resistant granules, Salofalk 3g gastro-resistant prolonged-release granules | Dr. Falk Pharma GmbH, Dr. Falk Pharma GmbH | acute ulcerative colitis, acute ulcerative colitis - inflammation and ulcers of the colon and rectum, Diseases [C] - Digestive System Diseases [C06] | | | | |
